Residual Inflammation and Plaque Progression Long-term Evaluation (RIPPLE)

  • STATUS
    Recruiting
  • End date
    Oct 1, 2023
  • participants needed
    40
  • sponsor
    University of Cambridge
Updated on 24 April 2022
atherosclerosis
angiography
computed tomography angiography
coronary artery disease
infarction
myocardial infarction
infarct
coronary ct
MRI

Summary

Inflammation drives atherosclerotic plaque rupture triggering most acute coronary syndromes. Despite advances in diagnosis and management of atherosclerosis, patients with myocardial infarction (MI) remain at increased risk of recurrent events. The RIPPLE study aims to examine the relationship between residual coronary inflammation detected by 68Ga-DOTATATE PET in patients treated for MI to long-term plaque progression measured by CT coronary angiography (CTCA). The association between infarct-related myocardial 68Ga-DOTATATE PET and myocardial function and viability will also be assessed.

Description

While vascular inflammation can be detected using 18F-FDG PET, this method lacks inflammatory cell specificity and is unreliable for coronary imaging because of high background signals from the myocardium. Upregulation of somatostatin receptor subtype-2 (SST2) occurs in activated macrophages, offering a novel inflammation imaging target. 68Ga-DOTATATE, an SST2 PET tracer with low myocardial binding, shows promise for imaging coronary inflammation. Having previously demonstrated increased 68Ga-DOTATATE signals in coronary atherosclerotic lesions post-MI, we now aim to study the natural history of residual arterial inflammation in non-culprit arteries and better understand how 68Ga-DOTATATE signals relate to plaque morphology, progression and rupture. Residual infarct-related myocardial inflammation and its association with ischemic myocardial remodelling will also be examined.

Details
Condition Atherosclerosis, Myocardial Infarction, Coronary Artery Disease, Inflammation
Treatment Cardiac MRI, PET Imaging, Coronary CT Angiography
Clinical Study IdentifierNCT04073810
SponsorUniversity of Cambridge
Last Modified on24 April 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Male or female participants >18 years old
Able to give written, informed consent and to lie flat
First-presentation of myocardial infarction within ~2 weeks
At least mild non-culprit coronary artery disease on angiography, managed medically

Exclusion Criteria

Women of child bearing potential not using adequate contraception
Contrast allergy or contrast-nephropathy
Uncontrolled atrial fibrillation
Chronic kidney disease (eGFR <30 mL/min/1.73 m2)
Any medical condition, in the opinion of the investigator, that prevents the participant from lying flat during scanning, or from participating in the study
Uncontrolled chronic inflammatory disorder
History of recent malignancy deemed relevant to the study by the investigator
Current use of systemic corticosteroids
Previous coronary artery bypass grafting surgery (CABG) or percutaneous coronary intervention (PCI) before the index event
Contraindication to coronary angiography
Requires CABG or staged non-culprit artery PCI
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note